# Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy

> **NCT05725720** · — · RECRUITING · sponsor: **University of Bologna** · enrollment: 90 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** Gut microbiome analysis

## Key facts

- **NCT ID:** NCT05725720
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-23
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05725720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05725720, "Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05725720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*